Rep. Greg Landsman

Maddy summaryThis bill would amend the Anti-Terrorism Act of 1987 to designate the Muslim Brotherhood as a terrorist organization and prohibit its operations within the United States. It would require the President to designate the Muslim Brotherhood as a foreign terrorist organization under immigration law and impose new visa restrictions, including immediate revocation of current visas, for individuals identified as members. The bill mandates annual reports from the Secretary of State identifying Muslim Brotherhood branches worldwide and determining which should be designated as terrorist organizations under existing laws. These provisions would directly affect Muslim Brotherhood members, branches, and affiliated organizations seeking entry to or operating within the United States.

Maddy summaryThis bill requires Medicare Advantage and prescription drug plans to reimburse the Department of Veterans Affairs (VA) for health care services provided to veterans enrolled in those plans, including outpatient care, prescription drugs, and inpatient services. It establishes a new process for the VA to recover costs from Medicare plans, requiring these plans to respond to reimbursement claims within 45 days and face penalties for non-compliance, including triple damages for willful violations. The law modifies existing VA authority to recover costs for non-service-connected disabilities by clarifying recovery procedures and requiring Medicare plans to coordinate benefits with VA care. The provisions apply to Medicare plan years beginning January 1, 2026, and directly affect Medicare Advantage organizations and prescription drug plan sponsors that serve veterans. This policy change ensures veterans receive full benefits without double payments by requiring Medicare plans to reimburse the VA for services they cover.

Maddy summaryHRES 856 is a non-binding resolution expressing the House of Representatives' view that the U.S. Department of Agriculture (USDA) should use its existing contingency funds and interchange authority to fund the Supplemental Nutrition Assistance Program (SNAP) for November 2025. The resolution cites that the USDA holds over $5 billion in contingency funds set aside for emergencies and has legal authority under the Department of Agriculture Organic Act to transfer funds between nutrition programs to maintain SNAP benefits. This would directly support approximately 42 million people relying on SNAP, including 16 million children, 8 million seniors, 4 million people with disabilities, and 1.2 million veterans, preventing disruption during a potential funding gap. The resolution does not create new law but urges the administration to use existing resources to ensure continued food assistance.

Maddy summaryHR 6361, the Ban AI Denials in Medicare Act, prohibits the U.S. Department of Health and Human Services from implementing or testing Medicare models that use artificial intelligence for prior authorization of covered services under traditional Medicare. Specifically, it blocks the existing WISeR model (described in a 2025 federal notice) and prevents future models from using AI to deny coverage for Medicare Part A or Part B services. This bill directly affects Medicare beneficiaries and healthcare providers who would otherwise face AI-driven coverage decisions. The key mechanism is an amendment to the Social Security Act, explicitly banning the use of AI in prior authorization systems within Medicare's innovation models.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryHR 6255, the Affordable Insulin Now Act, requires health insurance plans (including employer-sponsored and individual plans) to cover specific insulin products starting in 2026. It caps out-of-pocket costs for these insulin products at $35 per 30-day supply or 25% of the negotiated price, whichever is lower, with no deductibles applied. The bill defines "selected insulin products" to include at least one of each dosage form (like vials or pumps) and type (such as rapid-acting or long-acting) available from the plan. This directly affects people with diabetes who rely on insulin, ensuring more predictable and affordable access to essential medications under their health coverage.

Maddy summaryThis bill directs the Health and Human Services Secretary to study federal, state, and private programs supporting job training and apprenticeships for current and former foster youth, evaluating effectiveness, gaps, and barriers. It then establishes the "Fostering the Future Pipeline Program" to provide competitive grants to states, schools, employers, and nonprofits for expanding industry-aligned training in high-demand fields like healthcare and IT, with a $50 million annual funding limit. The bill also amends existing foster care funding to allow education vouchers to cover short-term career programs, such as registered apprenticeships and certificate courses. These changes directly affect foster youth transitioning to adulthood by improving access to career pathways and workforce opportunities.

Maddy summaryHR 6215, the Small Business RELIEF Act, exempts small businesses from import duties imposed under Executive Order 14257 (90 Fed. Reg. 15041) for goods they import or use. It requires the President to refund duties paid by small businesses within 90 days of the bill's enactment. The bill defines "small business concern" using the standard Small Business Act criteria (15 U.S.C. 632). This directly affects small businesses importing goods, providing immediate cost relief by removing a specific tariff and refunding past payments.

Maddy summaryThe Revitalize Our Neighborhoods Act of 2025 creates a competitive grant program administered by the Department of Housing and Urban Development (HUD) to eliminate blight and revitalize neighborhoods. It provides funding specifically for states, local governments, or multi-jurisdictional entities to carry out activities like demolishing deteriorated structures, boarding vacant properties, renovating abandoned buildings, and constructing affordable housing - all limited to low-income communities. Recipients must contribute at least 15% in matching funds (from federal programs, local sources, or property sales) and submit detailed 5-year plans for how the funds will be used. The bill prohibits using funds to acquire occupied homes and requires annual reports on project outcomes, geographic distribution, and populations assisted.

Maddy summaryThis bill expands Medicare's drug price negotiation program to cover 50 drugs (up from 20) and requires health insurers to apply negotiated prices to cost-sharing for beneficiaries. It establishes annual out-of-pocket cost-sharing limits for prescription drugs under group health plans and insurance coverage, with specific limits of $2,000 for self-only coverage in 2027 that will increase annually. The bill also sets specific cost-sharing limits for insulin products, requiring coverage with no deductible and cost-sharing of no more than $35 per 30-day supply or 25% of the negotiated price. These provisions affect Medicare beneficiaries, people with group health plans, and health insurers across the country. The bill applies to plan years beginning on or after January 1, 2027.